Toleration and bioavailability of gemfibrozil in healthy men.
作者信息
Smith T C
出版信息
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):24-7. doi: 10.1177/00359157760690S206.
Abstract
摘要
相似文献
1
Toleration and bioavailability of gemfibrozil in healthy men.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):24-7. doi: 10.1177/00359157760690S206.
2
Preliminary observations on the effect of gemfibrozil on the excretion of faecal bile acids.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):112-4. doi: 10.1177/00359157760690S230.
3
Structure/activity relationship of gemfibrozil (CI-719) and related compounds.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):3-5. doi: 10.1177/00359157760690S202.
4
Gemfibrozil: a new lipid lowering agent. Open forum.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):115-20. doi: 10.1177/00359157760690S231.
5
6
The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):6-10. doi: 10.1177/00359157760690S203.
7
Hypolipidaemic action of gemfibrozil in adult nephrotics.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):47-8. doi: 10.1177/00359157760690S212.
8
Lipokinetic studies with gemfibrozil (CI-719).
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):94-7. doi: 10.1177/00359157760690S224.
9
Effect of gemfibrozil on lipolysis in dogs in vivo.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):107-8. doi: 10.1177/00359157760690S228.
10
Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):71-5. doi: 10.1177/00359157760690S217.
引用本文的文献
1
Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.
Drugs. 1988 Sep;36(3):314-39. doi: 10.2165/00003495-198836030-00004.
2
Gemfibrozil absorption and elimination in kidney and liver disease.
Klin Wochenschr. 1990 Jul 5;68(13):692-8. doi: 10.1007/BF01667018.
Zotero 插件